HS Code 30069300 - placebos for clinical trials

Placebos and blinded or double-blinded clinical trial kits for a recognised clinical trial, put up in measured doses

Examples (No official information or warranty)

- Placebo tablets for a double-blinded clinical trial, packaged in measured doses of 10 mg per tablet (30 tablets per box).
- Blinded clinical trial kits containing placebo capsules, each capsule measured at 5 mg (100 capsules per kit).
- Double-blinded clinical trial kits with placebo injections, pre-filled syringes containing 1 mL doses (50 syringes per kit).
- Placebo oral solution for a recognised clinical trial, measured in 15 mL doses (12 bottles per kit).
- Blinded clinical trial kits with placebo patches, each patch delivering 2 mg over 24 hours (28 patches per kit).
- Double-blinded clinical trial kits containing placebo inhalers, with 120 measured doses per inhaler (3 inhalers per kit).
- Placebo lozenges for a recognised clinical trial, each lozenge measured at 7.5 mg (20 lozenges per pack).

Code Tree Structure / Hierarchy

    3006 Pharmaceutical goods specified in note 4 to this chapter Other 30069300 Placebos and blinded (or double-blinded) clinical trial kits for a recognised clinical trial, put up in measured doses

Trade restrictions and policies

Chapter 30
21 Trade restrictions and policies
Position 3006
0 Trade restrictions and policies
Subheading 300693
3 Trade restrictions and policies
Customs Tariff Number 30069300
2022-01-01
ERGA OMNES (1011)
Third country duty
Regulation 1832/21
2025-01-01
ERGA OMNES (1011)
Import control of fluorinated greenhouse gases
Regulation 0573/24
2025-01-31
All third countries (1008)
Export control of fluorinated greenhouse gases
Regulation 0573/24

Changes to this tariff number

Changes in favor of 30069300
2021: 30049000
2022: 30069300